BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 20542796)

  • 41. A risk score to predict bleeding in patients with acute coronary syndromes.
    Mehran R; Pocock SJ; Nikolsky E; Clayton T; Dangas GD; Kirtane AJ; Parise H; Fahy M; Manoukian SV; Feit F; Ohman ME; Witzenbichler B; Guagliumi G; Lansky AJ; Stone GW
    J Am Coll Cardiol; 2010 Jun; 55(23):2556-66. PubMed ID: 20513595
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of antiplatelet agents and anticoagulants for cardiovascular disease: current standards and best practices.
    Faxon DP
    Rev Cardiovasc Med; 2005; 6 Suppl 4():S3-14. PubMed ID: 17710074
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dual antiplatelet therapy in coronary artery disease: a case-based approach.
    Raymond C; Menon V
    Cleve Clin J Med; 2009 Nov; 76(11):663-70. PubMed ID: 19884296
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiplatelet intervention in acute coronary syndrome.
    Arora RR; Rai F
    Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI.
    Otterstad JE; Brosstad F
    Scand Cardiovasc J; 2004 Mar; 38(1):9-15. PubMed ID: 15204241
    [No Abstract]   [Full Text] [Related]  

  • 46. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.
    Reaume KT; Regal RE; Dorsch MP
    Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Road mapping ATLAS ACS 2: are we there yet?
    Armstrong PW; Harrington RA
    Eur Heart J; 2012 Oct; 33(20):2510-2. PubMed ID: 22297122
    [No Abstract]   [Full Text] [Related]  

  • 48. Significant gastrointestinal bleeding in patients at risk of coronary stent thrombosis.
    Dai X; Makaryus AN; Makaryus JN; Jauhar R
    Rev Cardiovasc Med; 2009; 10(1):14-24. PubMed ID: 19367228
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Strategies to minimize bleeding complications of percutaneous coronary intervention.
    White HD
    Curr Opin Cardiol; 2009 Jul; 24(4):273-8. PubMed ID: 19474710
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SES for AMI: moving in the right direction.
    Vetrovec GW
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):333-4. PubMed ID: 19642181
    [No Abstract]   [Full Text] [Related]  

  • 51. The devastating consequences of thrombosis of systemico pulmonary shunts and the blind administration of aspirin.
    d'Udekem Y
    Thromb Res; 2010 Sep; 126(3):163. PubMed ID: 20667585
    [No Abstract]   [Full Text] [Related]  

  • 52. Antithrombotic therapy in peripheral artery disease--antiplatelet therapy, anticoagulants, both or none.
    Tangelder MJ; van Hattum ES
    Thromb Haemost; 2010 Aug; 104(2):196-9. PubMed ID: 20508897
    [No Abstract]   [Full Text] [Related]  

  • 53. Periprocedural management of antithrombotic therapy in hospitalized patients.
    Feinbloom D
    J Hosp Med; 2014 May; 9(5):337-46. PubMed ID: 24550198
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention.
    Parikh SV; Keeley EC
    Vasc Health Risk Manag; 2009; 5():677-91. PubMed ID: 19707287
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Focus on pharma in acute coronary syndrome.
    Agewall S
    Eur Heart J Cardiovasc Pharmacother; 2020 Jan; 6(1):1-2. PubMed ID: 31909430
    [No Abstract]   [Full Text] [Related]  

  • 56. Antithrombotic therapy after percutaneous coronary intervention in anticoagulated patients: a fine balance between thrombosis and bleeding.
    Ghattas A; Shantsila E; Lip GY
    Ther Adv Cardiovasc Dis; 2011 Feb; 5(1):5-9. PubMed ID: 21282200
    [No Abstract]   [Full Text] [Related]  

  • 57. Antithrombotic therapy in 2017: Advances in atherosclerosis, atrial fibrillation, and valvular disease.
    Bhatt DL
    Nat Rev Cardiol; 2018 Feb; 15(2):71-72. PubMed ID: 29297509
    [No Abstract]   [Full Text] [Related]  

  • 58. Return of Oral Anticoagulation in Chronic Stable Coronary Disease.
    Verheugt FWA
    Circulation; 2018 Apr; 137(16):1655-1657. PubMed ID: 29661947
    [No Abstract]   [Full Text] [Related]  

  • 59. Thrombosis in congenital heart disease.
    Khairy P
    Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1579-82. PubMed ID: 24215186
    [No Abstract]   [Full Text] [Related]  

  • 60. Management of acute coronary syndrome in patients with non-valvular atrial fibrillation: results of the European Heart Rhythm Association Survey.
    Potpara TS; Lip GY; Dagres N; Estner HL; Larsen TB; Blomström-Lundqvist C;
    Europace; 2014 Feb; 16(2):293-8. PubMed ID: 24478291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.